Adora Ndu, Pharm.D., J.D., has served as an ACADIA director since October 2022. She is Chief Regulatory Officer and Executive Vice President of Portfolio Strategy and Management at BridgeBio Pharma, which she joined in 2022, and previously held regulatory leadership roles at BioMarin Pharmaceutical and served in various roles at the U.S. Food and Drug Administration from 2008 to 2016, most recently as a Division Director in the Division of Medical Policy Development. She currently serves on the board of DBV Technologies. She earned her Pharm.D. from Howard University and her J.D. from the University of Maryland.